1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Category Archives: Immunosuppressive Drugs

31Jan/12

Fusion IP high on drug success – ShareCast

January 31, 2012Immunosuppressive Drugsadmin

Proactive Investors UKFusion IP high on drug successShareCastDiurnal is attempting to develop Chronocort, a modified release therapy that delivers hydrocortisone in a manner that mimics the body's normal circadian rhythm (the body's natural 24-…

31Jan/12

Biomerica Launches New Patented Test to Identify Individuals at Risk of … – MarketWatch (press release)

January 31, 2012Immunosuppressive Drugsadmin

Biomerica Launches New Patented Test to Identify Individuals at Risk of …MarketWatch (press release)The most commonly used thiopurine drug is called azathioprine. It is estimated that one in every 300 people lacks TPMT, which is an enzyme that helps …

31Jan/12

Buy Biocon; target of Rs 320: Unicon Investment – Moneycontrol.com

January 31, 2012Immunosuppressive Drugsadmin

Moneycontrol.comBuy Biocon; target of Rs 320: Unicon InvestmentMoneycontrol.comImmuno-suppressants grew by 40% YoY backed by strong Tacrolimus and MMF sales. Contract research services vertical posted a robust growth of 42% YoY. Biopharmaceutical divis…

30Jan/12

Pancrelipases, Xerese Cream Returned for Routine Monitoring – Medscape

January 30, 2012Immunosuppressive Drugsadmin

Pancrelipases, Xerese Cream Returned for Routine MonitoringMedscapeJanuary 30, 2012 — Three forms of pancrelipase and an acyclovir/hydrocortisone cream were recommended for return to routine monitoring during an abbreviated review as part of the US F…

30Jan/12

Preop evaluation mandatory before refractive IOL implantation – ModernMedicine

January 30, 2012Immunosuppressive Drugsadmin

Preop evaluation mandatory before refractive IOL implantationModernMedicineThis patient was treated preoperatively with a topical prednisolone acetate 1% and cyclosporine (Restasis, Allergan), which, 1 week later, resulted in more consistent astigmatis…

30Jan/12

Study identified predictive factors for neuroendocrine tumor progression – HemOncToday

January 30, 2012Immunosuppressive Drugsadmin

Study identified predictive factors for neuroendocrine tumor progressionHemOncTodayResearchers also found that a combination of the drug everolimus (Afinitor, Novartis) with octreotide acetate arrested neuroendocrine tumor development longer vs. octreo…

30Jan/12

In vivo and in vitro effects of RAD001 on bladder cancer – Abstract – UroToday

January 30, 2012Immunosuppressive Drugsadmin

In vivo and in vitro effects of RAD001 on bladder cancer – AbstractUroTodayOBJECTIVE: To evaluate the influence of Everolimus (RAD001) on chemically induced urothelial lesions in mice and its influence on in vitro human bladder cancer cell lines. METHO…

27Jan/12

New Psoriasis Guidelines Expand Treatment Options – MedPage Today

January 27, 2012Immunosuppressive Drugsadmin

New Psoriasis Guidelines Expand Treatment OptionsMedPage TodayPoint out that conventional drugs such as methotrexate and cyclosporine often are effective, but have significant toxicities, including liver problems with methotrexate and kidney problems w…

27Jan/12

Nanotech transforms cyclosporine into safer transplant drug – FierceDrugDelivery

January 27, 2012Immunosuppressive Drugsadmin

Nanotechnology NewsNanotech transforms cyclosporine into safer transplant drugFierceDrugDeliveryThe Times of India reports that researchers at the University of Strathclyde in Scotland are working on a nano-sized drug particle version of cyclosporine, …

27Jan/12

FDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney Cancer – Sacramento Bee

January 27, 2012Immunosuppressive Drugsadmin

WANEFDA Approves Inlyta To Treat Patients With a Type of Advanced Kidney CancerSacramento BeeRecently approved drugs for the treatment of kidney cancer include sorafenib (2005), sunitinib (2006), temsirolimus (2007), everolimus (2009), bevacizumab (200…

Posts navigation

  • « Previous
  • 1
  • …
  • 143
  • 144
  • 145
  • 146
  • 147
  • …
  • 172
  • Next »

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos